Back

Choose your region

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
2301 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
2302 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 8
2303 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
2304 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 26
2305 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 56
2306 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 63
2307 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 61
2308 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 70
2309 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Poland 66
2310 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Germany 48
2311 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Germany 58
2312 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2021 Standard Therapy Germany 59
2313 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 62
2314 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 63
2315 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 64
2316 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 66
2317 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 65
2318 Apheresis Allogeneic Myelofibrosis Hematology 2021 Standard Therapy Poland 56
2319 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 75
2320 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 65
2321 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 51
2322 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 63
2323 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 75
2324 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2021 Standard Therapy Poland 64
2325 Apheresis Allogeneic Myeloma Multiplex Hematology 2021 Standard Therapy Poland 48
2326 Apheresis Allogeneic Myeloma Multiplex Hematology 2021 Standard Therapy Poland 53
2327 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2021 Standard Therapy Poland 67
2328 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2021 Standard Therapy Poland 58
2329 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2021 Standard Therapy Germany 51
2330 Apheresis Allogeneic No Data Hematology 2021 Standard Therapy Poland 64
2331 Apheresis Allogeneic No Data Hematology 2021 Standard Therapy Poland 57
2332 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 30
2333 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 51
2334 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 58
2335 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 56
2336 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 58
2337 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 50
2338 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 53
2339 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 20
2340 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 64
2341 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Poland 66
2342 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 62
2343 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 61
2344 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 49
2345 Apheresis Allogeneic Non-Hodgkin-Lymphoma-Relapse Hematology 2021 Standard Therapy Germany 62
2346 Apheresis Allogeneic Osteomyelitis Hematology 2021 Standard Therapy Poland 47
2347 Apheresis Allogeneic Osteomyelofibrosis Hematology 2021 Standard Therapy Poland 69
2348 Apheresis Allogeneic Osteomyelofibrosis Hematology 2021 Standard Therapy Poland 43
2349 Apheresis Autologous Osteosclerotic Myeloma Hematology 2021 Standard Therapy Germany 54
2350 Apheresis Allogeneic Other Myelodysplastic Syndromes Hematology 2021 Standard Therapy Poland 65
2351 Apheresis Allogeneic Other Myelofibrosis Hematology 2021 Standard Therapy Poland 68
2352 Apheresis Allogeneic Other Myelofibrosis Hematology 2021 Standard Therapy Poland 70
2353 Apheresis Allogeneic Other Myelofibrosis Hematology 2021 Standard Therapy Poland 72
2354 Apheresis Allogeneic Other Plasma Cell Disorder Hematology 2021 Standard Therapy Poland 67
2355 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2021 Standard Therapy Poland 45
2356 Apheresis Allogeneic Philadelphia-Positive Acute Lymphoblastic Leukemia Hematology 2021 Standard Therapy Poland 61
2357 Apheresis Allogeneic Polycythemia Vera Hematology 2021 Standard Therapy Poland 65
2358 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 71
2359 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 66
2360 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 62
2361 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 53
2362 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 44
2363 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 54
2364 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 65
2365 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 65
2366 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2021 Standard Therapy Germany 60
2367 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 66
2368 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 63
2369 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 62
2370 Apheresis Allogeneic Primary Myelofibrosis Hematology 2021 Standard Therapy Poland 64
2371 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2021 Standard Therapy Poland 68
2372 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2021 Standard Therapy Poland 64
2373 Apheresis Allogeneic Refractory Cytopenia Hematology 2021 Standard Therapy Poland 6
2374 Apheresis Allogeneic Secondary Acute Lymphoblastic Leukemia From Chronic Myeloid Leukemia Hematology 2021 Standard Therapy Poland 58
2375 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 70
2376 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 64
2377 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 39
2378 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2021 Standard Therapy Germany 60
2379 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 35
2380 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 58
2381 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 41
2382 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2021 Standard Therapy Poland 38
2383 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2021 Standard Therapy Poland 1
2384 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2021 Standard Therapy Poland 1
2385 Apheresis Allogeneic T-Cell Lymphoblastic Lymphoma Hematology 2021 Standard Therapy Germany 26
2386 Apheresis Allogeneic T-Cell Lymphoblastic Lymphoma Hematology 2021 Standard Therapy Germany 37
2387 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 54
2388 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 66
2389 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 66
2390 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2021 Standard Therapy Germany 29
2391 Apheresis Allogeneic T-Cell-Lymphoma Hematology 2021 Standard Therapy Poland 45
2392 Apheresis Autologous Testicular Cancer Hematology 2021 Standard Therapy Germany 33
2393 Apheresis Allogeneic Β – Thalassemia Hematology 2021 Standard Therapy Poland 17
2394 Adipose Tissue Autologous Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 51,1
2395 Adipose Tissue Autologous Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 44,4
2396 Adipose Tissue Autologous Gonarthrosis Orthopedy 2021 Experimental Therapy Poland 35,8
2397 Adipose Tissue Autologous Internal Damage To The Knee Joint Orthopedy 2021 Experimental Therapy Poland 40.9
2398 Adipose Tissue Autologous Soft Tissue Diseases Related To Use, Overload And Pressure Orthopedy 2021 Experimental Therapy Poland 27,5
2399 Placenta blood Autologous Cerebral Palsy Neurology 2020 Experimental Therapy Poland 2,6
2400 Cord Tissue Allogeneic – Unrelated Covid-19 Pulmonology 2020 Experimental Therapy Poland 84,5